Atypical Femoral Fractures and Bone Turnover

Authors:

Abstract
Epidemiologic studies and case series and reports suggest that there is a relation between the long-term use of bisphosphonates and the development of atypical femoral fractures.1 Although the cause of such fractures is unknown, the fact that bisphosphonates decrease bone resorption and formation and also have a long half-life in bone has led to the common belief that atypical fractures associated with bisphosphonate use are due to the marked suppression of bone turnover, resulting in the accumulation of microdamage that can lead to fractures.